AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimenova M 1 mg/500 mg Tablet SR

Prescription Icon
Prescription Required

Marketer

TTK Healthcare Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimenova M 1 mg/500 mg Tablet SR

Diabetic patients using Glimepiride/Metformin 1mg/500mg extended-release tablets should be aware that this anti-diabetic medication, a dual-agent formulation, manages type 2 diabetes in adults by regulating blood glucose. Consistent daily intake, ideally with meals, at the same time, is crucial for optimal efficacy. Dosage is determined individually by your physician and may adjust based on blood sugar monitoring. Discontinuing this medication without medical supervision is strongly discouraged; abrupt cessation can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is but one component of a comprehensive diabetes management plan, which also mandates a healthy diet, regular exercise, and weight management as recommended by your healthcare provider. Lifestyle modifications are critical to successful diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, lightheadedness, headache, and tremors. Knowing the symptoms and having readily available fast-acting glucose (e.g., sugary snacks or juice) is vital. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Patients with a history of cardiovascular disease should discuss its suitability with their doctor before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Glimenova M 1 mg/500 mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Glimenova M 1 mg/500 mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimenova M 1 mg/500 mg Extended-Release tablets with a meal.

Common Side effects of Glimenova M 1 mg/500 mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimenova M 1 mg/500 mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimenova M 1 mg/500 mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with food.

How Glimenova M 1 mg/500 mg Tablet SR works:

Glimenova M 1 mg/500 mg Extended-Release Tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimenova M 1 mg/500 mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimenova M 1 mg/500 mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Glimenova M 1 mg/500 mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Glimenova M 1 mg/500 mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. In cases of severe kidney disease, Glimenova M 1 mg/500 mg SR tablets are contraindicated. Close monitoring of kidney function is recommended throughout the treatment period.

LiverLiverCAUTION

Individuals with liver impairment should use Glimenova M 1 mg/500 mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation with a low dose of Glimenova M 1 mg/500 mg Tablet SR is typical; however, its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimenova M 1 mg/500 mg Tablet SR :

Should you forget a Glimenova M 1 mg/500 mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimenova M 1 mg/500 mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimenova M 1 mg/500 mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimenova M 1 mg/500 mg Tablet SR can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimenova M and seek immediate medical attention.
Glimenova M 1 mg/500 mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimenova M 1 mg/500 mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimenova M 1 mg/500 mg Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimenova M 1 mg/500 mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimenova M 1 mg/500 mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, increasing the risk of hypoglycemia and lactic acidosis.
Glimenova M 1 mg/500 mg T...
52
MRP 60
13% off